SE0102380D0 - Kräm för behandling av åldersförändringar i huden hos människa - Google Patents

Kräm för behandling av åldersförändringar i huden hos människa

Info

Publication number
SE0102380D0
SE0102380D0 SE0102380A SE0102380A SE0102380D0 SE 0102380 D0 SE0102380 D0 SE 0102380D0 SE 0102380 A SE0102380 A SE 0102380A SE 0102380 A SE0102380 A SE 0102380A SE 0102380 D0 SE0102380 D0 SE 0102380D0
Authority
SE
Sweden
Prior art keywords
cream
weight
treatment
man
skin
Prior art date
Application number
SE0102380A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Andersson
Ulf Starlander
Bjoern Andersson
Original Assignee
Macronova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macronova Ab filed Critical Macronova Ab
Priority to SE0102380A priority Critical patent/SE0102380D0/xx
Publication of SE0102380D0 publication Critical patent/SE0102380D0/xx
Priority to DE60217356T priority patent/DE60217356T2/de
Priority to DK02747792T priority patent/DK1411889T3/da
Priority to RU2003137600/15A priority patent/RU2313333C2/ru
Priority to PCT/SE2002/001308 priority patent/WO2003037291A1/en
Priority to EP02747792A priority patent/EP1411889B1/en
Priority to CN028131169A priority patent/CN1713888B/zh
Priority to CA002450726A priority patent/CA2450726A1/en
Priority to PT02747792T priority patent/PT1411889E/pt
Priority to NZ530226A priority patent/NZ530226A/en
Priority to AU2002318699A priority patent/AU2002318699B2/en
Priority to ES02747792T priority patent/ES2280554T3/es
Priority to BR0210760-0A priority patent/BR0210760A/pt
Priority to MXPA03011509A priority patent/MXPA03011509A/es
Priority to KR1020037017319A priority patent/KR100885347B1/ko
Priority to AT02747792T priority patent/ATE349998T1/de
Priority to JP2003539635A priority patent/JP2005507406A/ja
Priority to NO20035715A priority patent/NO20035715D0/no
Priority to US10/482,694 priority patent/US20050152856A2/en
Priority to US11/642,948 priority patent/US20070212431A1/en
Priority to CY20071100415T priority patent/CY1107600T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicinal Preparation (AREA)
SE0102380A 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa SE0102380D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa
JP2003539635A JP2005507406A (ja) 2001-07-02 2002-06-30 日光によって損傷を受けた皮膚の治療用クリーム
PT02747792T PT1411889E (pt) 2001-07-02 2002-06-30 Creme para o tratamento de pele danificada pelo sol
AU2002318699A AU2002318699B2 (en) 2001-07-02 2002-06-30 Cream for treatment of skin injured by the sun
RU2003137600/15A RU2313333C2 (ru) 2001-07-02 2002-06-30 Крем для лечения кожи, поврежденной солнцем
PCT/SE2002/001308 WO2003037291A1 (en) 2001-07-02 2002-06-30 Cream for treatment of skin injured by the sun
EP02747792A EP1411889B1 (en) 2001-07-02 2002-06-30 Cream for treatment of skin injured by the sun
CN028131169A CN1713888B (zh) 2001-07-02 2002-06-30 用于治疗被太阳损伤的皮肤的膏霜
CA002450726A CA2450726A1 (en) 2001-07-02 2002-06-30 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
DE60217356T DE60217356T2 (de) 2001-07-02 2002-06-30 Creme zur behandlung von sonnengeschädigter haut
NZ530226A NZ530226A (en) 2001-07-02 2002-06-30 Cream comprising D, L-alpha-lipoic acid, coenzyme Q-10 and acetyl-L-carnitine hydrochloride for the treatment of sun injured skin
DK02747792T DK1411889T3 (da) 2001-07-02 2002-06-30 Creme til behandling af hud, som er skadet af solen
ES02747792T ES2280554T3 (es) 2001-07-02 2002-06-30 Crema para el tratamiento de la piel dañada por el sol.
BR0210760-0A BR0210760A (pt) 2001-07-02 2002-06-30 Creme facial para tratamento tópico de pele fotodanificada, e, método para preparar um creme
MXPA03011509A MXPA03011509A (es) 2001-07-02 2002-06-30 Crema para tratamiento de piel lesionada por el sol.
KR1020037017319A KR100885347B1 (ko) 2001-07-02 2002-06-30 햇빛에 의해 손상된 피부를 치료하기 위한 크림
AT02747792T ATE349998T1 (de) 2001-07-02 2002-06-30 Creme zur behandlung von sonnengeschädigter haut
NO20035715A NO20035715D0 (no) 2001-07-02 2003-12-19 Krem til behandling av solskadet hud
US10/482,694 US20050152856A2 (en) 2001-07-02 2004-06-21 Cream for treatment of skin injured by the sun
US11/642,948 US20070212431A1 (en) 2001-07-02 2006-12-21 Cream for treatment of skin injured by the sun
CY20071100415T CY1107600T1 (el) 2001-07-02 2007-03-26 Κρεμα για τη θepαπεια δερματος τραυματισμενου απο τον ηλιο

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa

Publications (1)

Publication Number Publication Date
SE0102380D0 true SE0102380D0 (sv) 2001-07-02

Family

ID=20284723

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa

Country Status (20)

Country Link
US (2) US20050152856A2 (ko)
EP (1) EP1411889B1 (ko)
JP (1) JP2005507406A (ko)
KR (1) KR100885347B1 (ko)
CN (1) CN1713888B (ko)
AT (1) ATE349998T1 (ko)
AU (1) AU2002318699B2 (ko)
BR (1) BR0210760A (ko)
CA (1) CA2450726A1 (ko)
CY (1) CY1107600T1 (ko)
DE (1) DE60217356T2 (ko)
DK (1) DK1411889T3 (ko)
ES (1) ES2280554T3 (ko)
MX (1) MXPA03011509A (ko)
NO (1) NO20035715D0 (ko)
NZ (1) NZ530226A (ko)
PT (1) PT1411889E (ko)
RU (1) RU2313333C2 (ko)
SE (1) SE0102380D0 (ko)
WO (1) WO2003037291A1 (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858932B1 (fr) * 2003-08-22 2009-10-30 Oreal Composition destinee a lutter contre la degradation des fibres de collagene induite en condition d'exposition solaire naturelle
ES2410587T3 (es) 2004-01-22 2013-07-02 University Of Miami Formulaciones tópicas de coenzima Q10 y métodos de uso
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
CN1723881A (zh) * 2005-06-23 2006-01-25 马开龙 含辅酶q10的治疗皮肤病的组合物及其制备方法
EP2136787B1 (en) 2007-03-22 2019-08-21 Berg LLC Topical formulations having enhanced bioavailability
US7999040B2 (en) * 2007-09-25 2011-08-16 Nanochem Solutions, Inc. Method of making graft copolymers from sodium poly(aspartate) and the resulting graft copolymer
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
CN103462896A (zh) 2008-04-11 2013-12-25 细胞研究有限公司 诱导癌细胞凋亡的方法和应用
KR101553074B1 (ko) 2008-07-17 2015-09-14 가천대학교 산학협력단 나노에멀젼 조성물
WO2010132479A2 (en) 2009-05-11 2010-11-18 Cytotech Labs, Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
EA201490047A1 (ru) 2011-06-17 2014-08-29 Берг Ллк Ингаляционные фармацевтические композиции
KR102279451B1 (ko) 2013-04-08 2021-07-19 버그 엘엘씨 코엔자임 q10 병용 요법을 이용한 암 치료
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
WO2020201377A1 (en) 2019-04-04 2020-10-08 Medica Clinical Nord Sverige Ab Cream for treatment of skin injured by the sun
SE543528C2 (en) * 2019-04-04 2021-03-16 Medica Clinical Nord Sverige Ab Cream for treatment of skin injured by the sun

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62175415A (ja) * 1986-01-27 1987-08-01 Kanebo Ltd 皮膚化粧料
JP2794433B2 (ja) * 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
AU6482596A (en) * 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
US5667791A (en) 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6015548A (en) * 1998-07-10 2000-01-18 Shaklee Corporation High efficiency skin protection formulation with sunscreen agents and antioxidants
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
CA2332948A1 (en) * 1998-04-24 1999-11-04 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposits skin care actives
JP2000063273A (ja) * 1998-08-20 2000-02-29 Noevir Co Ltd 免疫機能低下抑制剤
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US6048886A (en) 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
IT1312377B1 (it) * 1999-03-05 2002-04-15 Uni Ci S R L Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20020044913A1 (en) 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
DE10020874A1 (de) * 2000-04-28 2001-05-17 Murnauer Markenvertrieb Gmbh Kosmetisch-pharmazeutisches Kombinationspräparat
AU2001270554A1 (en) * 2000-06-06 2001-12-17 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
DE10059584A1 (de) * 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US20020119114A1 (en) * 2000-12-18 2002-08-29 Beiersdorf Aktiengesellschaft Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
DE10111048A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von alpha-Liponsäure zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Regeneration beanspruchter Haut, insbesondere der gealterten Haut
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging

Also Published As

Publication number Publication date
PT1411889E (pt) 2007-04-30
DK1411889T3 (da) 2007-05-07
CN1713888A (zh) 2005-12-28
WO2003037291A8 (en) 2004-05-13
KR100885347B1 (ko) 2009-02-26
ATE349998T1 (de) 2007-01-15
NO20035715D0 (no) 2003-12-19
US20050152856A2 (en) 2005-07-14
KR20040030728A (ko) 2004-04-09
RU2003137600A (ru) 2005-03-27
EP1411889A1 (en) 2004-04-28
ES2280554T3 (es) 2007-09-16
CY1107600T1 (el) 2013-03-13
EP1411889B1 (en) 2007-01-03
JP2005507406A (ja) 2005-03-17
RU2313333C2 (ru) 2007-12-27
CN1713888B (zh) 2011-01-26
US20040219114A1 (en) 2004-11-04
NZ530226A (en) 2005-08-26
WO2003037291A1 (en) 2003-05-08
MXPA03011509A (es) 2004-10-28
AU2002318699B2 (en) 2007-01-04
DE60217356D1 (de) 2007-02-15
US20070212431A1 (en) 2007-09-13
DE60217356T2 (de) 2007-10-11
BR0210760A (pt) 2004-07-20
CA2450726A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
CY1107600T1 (el) Κρεμα για τη θepαπεια δερματος τραυματισμενου απο τον ηλιο
MY137060A (en) Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis
WO2006131737A3 (en) Method and composition for treating inflammatory disorders
ATE374026T1 (de) Rho-kinase-inhibitoren für die vorbeugung oder behandlung von interstitieller pneumonie und pulmonaler fibrose
NO20070295L (no) Nye CIS-imidazoliner
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
SE9904765D0 (sv) Pharmaceutically-useful compounds
BRPI0408675A (pt) derivados de talidomida solúveis em água
HRP20050667A2 (en) Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
ATE232725T1 (de) Behandlung der migräne durch verabreichung von alpha-liponsäure oder derivaten derselben
DE60012028D1 (de) Zwischenprodukte für die herstellung von naphthyridin-3-carbonsäure-derivaten
ITRM20010445A1 (it) Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
EP1634589A4 (en) AQUEOUS OLANEXIDINE SOLUTION, MANUFACTURING METHOD AND DISINFECTANT
DE60108122D1 (de) Fumarsäuredoppelsalze mit carnitin und einer aminosäure und nahrungs- und lebensmittelzusätze und medikamente die diese enthalten
WO2003000700A3 (en) Ascorbyl derivatives of carnitines and cosmetic compositions containing same
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
WO2002070537A3 (en) Fusidic acid derivatives
DE60003074D1 (de) Fusidinsäure-derivate
WO2003090678A3 (en) Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
BR0215274A (pt) Alimentos ricos em netionina modificados e processos de sua fabricação
WO2002096218A3 (de) Kombination von liponsäuren, carnitinen und kreatinen in lebens- und arzneimitteln
ITMI950132A1 (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
CA2394230A1 (en) Novel stromelysin inhibitors